	US 11,986,457 B2
	Nutraceutical compositions
Sebastian Balcombe, Evergreen, CO (US); William Hamilton, Cambridge (GB); Jonathan Heal, Cambridge (GB); and Joseph Sheridan, Cambridge (GB)
Assigned to SPECNOVA LLC, Gainesville, FL (US)
Filed by SpecNova LLC, Evergreen, CO (US)
Filed on Mar. 16, 2022, as Appl. No. 17/655,015.
Claims priority of provisional application 63/162,324, filed on Mar. 17, 2021.
Prior Publication US 2022/0296562 A1, Sep. 22, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/353 (2006.01); A61K 45/06 (2006.01)

CPC A61K 31/353 (2013.01) [A61K 45/06 (2013.01)]

8 Claims

1. A nutraceutical composition comprising a compound selected from: agatharesinol or a nutraceutically acceptable derivative thereof, wherein the nutraceutically acceptable derivative of agatharesinol is sequirin C; or a nutraceutically acceptable salt or solvate thereof.